Last reviewed · How we verify
Heilongjiang Quanle Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Compound Ciwujia Granules, Guipi Granules | Compound Ciwujia Granules, Guipi Granules | marketed | Herbal combination / Traditional Chinese Medicine | General wellness / Constitutional support |
Therapeutic area mix
- General wellness / Constitutional support · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
Subscribe to ongoing alerts
Every new pipeline event for Heilongjiang Quanle Pharmaceutical Co., Ltd.:
- Heilongjiang Quanle Pharmaceutical Co., Ltd. pipeline updates — RSS
- Heilongjiang Quanle Pharmaceutical Co., Ltd. pipeline updates — Atom
- Heilongjiang Quanle Pharmaceutical Co., Ltd. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Heilongjiang Quanle Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/heilongjiang-quanle-pharmaceutical-co-ltd. Accessed 2026-05-17.